The exposure to fine particulate matter (PM) in reinforced concrete production.
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate – Biotech Investments
EQS-News: Biotest AG / Key word(s): Study results Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate 14.02.2024 / 08:30 CET/CEST The